SEC Form 4 · accession 0001144204-16-086460
Inspyr Therapeutics, Inc. · NSPX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Varde Ogilvie
Director
Period of report
Mar 1, 2016
Accepted (ET)
Mar 7, 2016 · 7:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001421204
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock purchase optionF1 | $0.14 | Mar 1, 2016 | A | 53,000 | A | Mar 1, 2016 | Mar 1, 2021 | Common Stock | 53,000 | 53,000 | D |
Explanation of responses
- F1Represents compensatory Annual Grant and Committee Grants for director services. The options vest quarterly on 6/1/16, 9/1/16, 12/1/16, and 3/1/17.